[TEVA] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -556.19%
YoY- -291.48%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 4,357,000 4,468,000 4,264,000 4,337,000 4,295,000 4,559,000 4,529,000 -2.54%
PBT -33,000 -38,000 -292,000 -850,000 -84,000 -3,387,000 -213,000 -71.12%
Tax -59,000 -119,000 11,000 -179,000 9,000 -139,000 -26,000 72.59%
NP 69,000 109,000 -314,000 -689,000 -105,000 -2,886,000 -208,000 -
Tax Rate - - - - - - - -
Total Cost 4,288,000 4,359,000 4,578,000 5,026,000 4,400,000 7,445,000 4,737,000 -6.41%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 1.58 2.44 -7.36 -15.89 -2.44 -63.30 -4.59 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 0.06 0.10 -0.29 -0.63 -0.10 -2.80 -0.21 -
EPS Diluted 0.06 0.10 -0.29 -0.63 -0.10 -2.80 -0.20 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.